23
Jun

Invictus MD Announces Inclusion On Horizons Marijuana Life Sciences Index ETF

Investor Relations

Vancouver, BC, June 23, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”), which is trading, and is the first ETF to offer direct exposure to North American-listed stocks that operate in the legal medical cannabis industry.

Horizon Medical Marijuana Life Sciences ETF is the first exchange-traded fund that offers investors direct exposure to North American-listed stocks that are involved with biopharmaceuticals, medical manufacturing, distribution, bio-products, and other businesses ancillary to the marijuana industry. Invictus MD joins the 19 other constituents. Only stocks that meet minimum asset and liquidity thresholds are qualified for inclusion in the index, and no single stock may exceed 10% of the weight of the Index when rebalanced.

“Invictus MD’s inclusion to Horizon’s Marijuana Life Sciences Index ETF represents an important achievement for our company and recognizes the enormous efforts and successes of our team,” said Dan Kriznic, Executive Chairman. “Inclusion in the ETF will help broaden participation in Invictus MD’s shares, and improve trading liquidity for our shareholders.”

About Invictus MD Strategies Corp.

Invictus MD Strategies Corp. is focused on two main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR, including its wholly owned subsidiary Acreage Pharms Ltd., as well as its investment in the fully licensed facility AB Laboratories Inc.; and Fertilizer and Nutrients through Future Harvest Development Ltd.

For more information, please visit www.invictus-md.com.

On Behalf of the Board,
Dan Kriznic
Executive Chairman

Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Recent Posts

INVICTUS’ ACREAGE PHARMS COMPLETES SHIPMENT OF RECREATIONAL CANNABIS TO BRITISH COLUMBIA

September 25, 2018

Invictus provides update on German partnership and EU-GMP certification

September 24, 2018

Invictus Hires Ex-Heineken Executive Kevin Smith As VP Recreational Sales; Sarah Hardy As VP Medical Sales

September 17, 2018

Invictus Acreage Pharms To Become A Registered Cannabis Supplier In Saskatchewan

September 11, 2018
 

Categories

Archives

 September 2018
 August 2018
 July 2018
 June 2018
 May 2018
 April 2018
 March 2018
 February 2018
 January 2018
 December 2017
 November 2017
 October 2017
 September 2017
 August 2017
 July 2017
 June 2017
 May 2017
 April 2017
 March 2017
 February 2017
 January 2017
 December 2016
 November 2016
 October 2016
 August 2016
 March 2016
 February 2016
 December 2015
 November 2015
 October 2015
 September 2015

Download our Investor Deck





Download our Investor Deck